Marshall Israel Hertz MD
Lung Transplantation Medicine
Professor, Medicine, University of Minnesota Medical School
Join to View Full Profile
Uniiversity of MinnesotaMMC 276Minneapolis, MN 55455
Dr. Hertz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Marshall Hertz is a pulmonologist in Minneapolis, MN. He received his medical degree from University of Michigan Medical School completed residency/fellowship at the University of Minnesota. He has been a UMN faculty member for 39 years, focusing primarily on lung transplant medicine and research/scholarship. He retired from clinical practice, but continues his role as an adviser to MD and MD/PhD students.
Education & Training
University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1984- University of MinnesotaResidency, Internal Medicine, 1978 - 1982
University of Michigan Medical SchoolClass of 1978
Certifications & Licensure
MN State Medical License 1982 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2007-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Microbiome and metabolome patterns after lung transplantation reflect underlying disease and chronic lung allograft dysfunction.Christian Martin, Kathleen S Mahan, Talia D Wiggen, Adam J Gilbertsen, Marshall I Hertz
Microbiome. 2024-10-09 - 1 citationsImpact of lung transplantation on diastolic dysfunction in recipients with pretransplant pulmonary hypertension.Rishav Aggarwal, Koray N Potel, Scott Jackson, Nicholas T Lemke, Rosemary F Kelly
The Journal of Thoracic and Cardiovascular Surgery. 2024-05-01 - 3 citationsTime since primary transplant and poor functional status predict survival after redo lung transplant.Rishav Aggarwal, Scott Jackson, Nicholas T Lemke, Lena Trager, Sara J Shumway
Journal of Thoracic Disease. 2022-10-01
Grant Support
- Bronchoalveolar Lavage Cell Biomarkers In Lung RejectionNational Heart, Lung, And Blood Institute2009–2010
- Pathogenesis And Therapy Of Chronic Lung RejectionNational Institute Of Allergy And Infectious Diseases2001–2005
- Gene Expression Microarrays In Lung RejectionNational Institute Of Allergy And Infectious Diseases2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
